Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 2Head & Neck 2Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Urinary Bladder, Neurogenic 1Urinary Bladder Diseases 1Malnutrition 1Endometriosis 1Cystitis, Interstitial 1Cystitis, Hemorrhagic 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Immunonutrition Diet × Genitourinary × Clear all
NCT05726786 2025-12-09

INCyst

Centre Hospitalier Universitaire Vaudois

Phase 3 Recruiting
232 enrolled
Genitourinary

Cystitis, Hemorrhagic, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic, Endometriosis, Cystitis, Interstitial, Malnutrition

NCT06355518 2024-04-09

INu-RC

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase NA Not yet recruiting
260 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡